Bionomics, Merck collaborate on drug development
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 24 Jun, 2014
Singapore: Australian biotech firm, Bionomics, has partnered with Merck for research and license agreement for its BNC37...Read more
Aussie start-up firm gets MRCF funding
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 16 Jan, 2015
Singapore: Australia's Medical Research Commercialisation Fund (MRCF) has funded the start-up firm Solvanix, an early st...Read more
Roche, Meiji Seika Pharma, Fedora collaborate to develop bacterial resistance to antibiotics
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 16 Jan, 2015
Singapore: Pharmaceutical firms, Roche, Meiji Seika Pharma and Fedora have entered into a license agreement for the deve...Read more
Taiwan firm Delta, A*Star launches diagnostics lab in Singapore
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 16 Jan, 2015
Singapore: Taiwan based Delta Electronics has invested in Singapore to develop next-generation infectious disease detec...Read more
Asia witnessing rise in COPD, says Dr David Price
Drug Discovery | Influencers | By BioSpectrum Bureau | 2 Comment | 06 Jul, 2012
Professor (Dr) David Price has been fighting the scourge of respiratory diseases throughout his life and is considered o...Read more
Eli Lilly opens diabetes R&D center in China
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 01 Jun, 2012
Singapore: Eli Lilly officially opened the Lilly China Research and Development Center (LCRDC) on May 30, keeping with i...Read more
Aussie firm progresses with cancer anorexia drug
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 29 Sep, 2014
Singapore: Australia-based biopharmaceutical company, Specialised Therapeutics Australia (STA), has achieved positive re...Read more
Alchemia recruits patients for rectal cancer trial
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 05 Feb, 2013
Singapore: Brisbane-based R&D company Alchemia has recruited the 390th patient for the pivotal phase III clinical tr...Read more
Non-Small Cell Lung Cancer treatment market to touch $7.9 bn by 2020'
Drug Discovery | Analysis | By BioSpectrum Bureau | 1 Comment | 11 Sep, 2014
Singapore: Global Non-Small Cell Lung Cancer (NSCLC) treatment market value will increase from USD5.1 billion in 2013 to...Read more
Amid rising concern, need for novel antibiotics
Drug Discovery | Analysis | By BioSpectrum Bureau | 1 Comment | 14 Mar, 2013
Singapore: Recent worries over antibiotics losing their effectiveness will only be exacerbated by the FDA's latest drug ...Read more
Bristol seeks Japanese nod of all-oral hepatitis C treatment
Drug Discovery | Regulatory | By BioSpectrum Bureau | 0 Comment | 04 Nov, 2013
Singapore: US drugmaker, Bristol-Myers Squibb co has said that it is seeking Japanese health regulators approval of its ...Read more
Orphan blood disease drugs to gain market
Drug Discovery | Analysis | By BioSpectrum Bureau | 2 Comment | 07 Feb, 2013
Singapore: Physicians treating rare blood disorders now have more drug treatments to choose from to treat patients. This...Read more
German, Korean firm join hands to discover cancer drugs
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 04 Jun, 2015
Singapore: Germany's translational drug discovery organization, Lead Discovery Center (LDC), has entered into a licence ...Read more
BMS, Pfizer gets FDA nod to review Eliquis
Drug Discovery | Regulatory | By BioSpectrum Bureau | 0 Comment | 12 Jul, 2013
Singapore: U.S. Food and Drug Administration (FDA) has accepted to review Supplemental New Drug Application (sNDA) for E...Read more
Eisai expands R&D in Belgium with office in Brussels
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 16 Sep, 2013
Singapore: Eisai EMEA (Europe, Middle East, Africa, Russia and Oceania), the R&D division of the Japan-based company...Read more
Genzyme's Cerdelga capsules approved in Japan
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 01 Apr, 2015
Genzyme, a Sanofi company, announced that the Ministry of Health, Labour and Welfare (MHLW) has granted marketing approv...Read more
GE to open technology and training centre in Turkey
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 17 Nov, 2014
Singapore: GE Healthcare Life Sciences plans to open a technology and training laboratory in Turkey by mid-2015 targetti...Read more
Takeda terminates prostrate cancer drug trial
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 24 Jun, 2014
Singapore: Takeda Pharmaceutical has terminated the development program for orteronel (TAK-700) for prostate cancer foll...Read more